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At present, more than 50000 plant species are used in phytotherapy and medicine. About 2/3 of them are harvested from nature
leadingtolocalextinctionofmanyspeciesordegradationoftheirhabitats.Biotechnologicalmethodsoﬀerpossibilitiesnotonlyfor
fastercloningandconservationofthegenotypeoftheplantsbutformodiﬁcationoftheirgeneinformation,regulation,andexpres-
sion for production of valuable substances in higher amounts or with better properties. Rhodiola rosea is an endangered medi-
cinal species with limited distribution. It has outstanding importance for pharmaceutical industry for prevention and cure of
cancer, heart and nervous system diseases, and so forth. Despite the great interest in golden root and the wide investigations in the
areaofphytochemistry,plantbiotechnologyremainedlessendeavouredandexploited.Thepaperpresentsresearchoninitiationof
in vitro cultures in Rhodiola rosea and some other Rhodiola species. Achievements in induction of organogenic and callus cultures,
regeneration,andmicropropagationvariedbutwereagoodbasisforalternativeinvitrosynthesisofthedesiredmetabolitesandfor
the development of eﬃcient systems for micropropagation for conservation of the species.
1.Introduction
Resent investigation of the World Health Organization
(WHO) recorded increasing utilization of herbs in the med-
ical practice [1]. The European market of medicinal plant
preparations and remedies has been stimulated by the
national policies for better exploitation of the advantages of
the traditional and the alternative medicine [2, 3]. The short
period of time from 1999 to 2001 marked a considerable
increase in the medicinal plants trade in many countries: in
the Czech Republic by 22%, in Turkmenistan by 100%, and
in Bulgaria by 170%. Similarly increasing herbs use in the
developed countries was recorded [4]. More than 25% of the
British population is taking them regularly [5]. The business
becomes more stable with sales income reaching 5 billion
USD for the period of 2003-2004 in Western Europe; 14
billion USD in China for the year of 2005, and 160 million
USD in Brazil for the year of 2007.
At present more than 50000 plant species are used in the
two major ﬁelds: the contemporary phytotherapy and the
modern allopathic medicine [4]. World-wide, about 2/3 of
those 50000 medicinal plants are harvested from nature [6].
The share of the cultivated plants used in the pharmaceu-
tical industry is quite small, yet, being only 10% in Europe
[5]. The number of natural populations is decreasing prog-
ressively leading to local extinction of many species or degra-
dationoftheirhabitats[7].AccordingtothedataoftheFood
and Agricultural Organization (FAO) at the United Nations
annually the ﬂora bares irretrievable losses which destroy the
natural resources and the ecological equilibrium [8]. Four
thousand to 10000 medicinal species were endangered of
disappearing during the last years [6].
Bulgaria is in the leading world positions in export of
wildmedicinalplants.Annualharvestvariesbetween15000t
and 17000t. Half of them are collected in the mountains
while 80% of them are exported [9–12]. Bulgarian medicinal
plants are famous for their high content of biologically active
substances. They are ranked in the ﬁrst world positions con-
sidering quality which is due to the speciﬁc climatic and soil
conditions of the country [13].2 The Scientiﬁc World Journal
However, the constant expansion of herbs trade, the
insuﬃcient cultivation ﬁelds, and the bad management of
harvesting and overharvesting have led to exhaustion of the
natural resources and reduction of the biodiversity. To stop
theviolenceagainstnature,eﬀortsshouldbedirectedtoboth
preservation of the plant populations and elevating the level
of knowledge for sustainable utilization of these plants in
medicine—traditional, alternative, and allopathic [4].
This great issue is in the focus of science which oﬀers
diﬀerentdecisionstosolvetheglobalproblem.Cultivationof
the valuable species in experimental conditions is one of the
approaches. The latter refers to application of classical meth-
ods for multiplication by cuttings, bulbs, and so forth, as
well as by biotechnological methods of in vitro cultures and
clonal propagation for production of enormous number of
identical plants. The micropropagation is considered to have
the greatest commercial and iconomical importance [14].
The modern techniques are especially appropriate for species
which are diﬃcult to propagate in vivo [15].
Biotechnological methods oﬀer possibilities not only for
faster cloning and conservation of the genotype of the plants
[14,16]butformodiﬁcationoftheirgeneinformation,regu-
lation and expression for production of valuable substances
in higher amounts or with better properties [15, 17]. Appli-
cation of integrative approaches to cultivation of plant sys-
tems could be a basis for future development of new, more
eﬀective, safe, and higher-quality products. Biotechnological
methods are reliable and provide continuous sources of raw
material and natural products for food, pharmaceutical, and
cosmetic industries [17–19].
2.Rhodiola rosea L.: Importance
andCharacterization
Rhodiola rosea is one of the endangered medicinal species
with outstanding economical importance determined by its
roots and rhizomes (Rhadix et Rhizoma Rhodiolae—rose
root) utilization in medicine and pharmacy for more than
thousands of years.
Golden root extracts have various properties—adapto-
genic, antitoxic, antihypoxic. They increase the body’s non-
speciﬁc resistance and normalize body functions by stimula-
tion of the own-body biochemical and functional reserves.
Rose root preparations regulate metabolism, the functions
of the central nervous system, the heart, and the hormonal
glands [20–23].
The chemical composition of the extracts from the
Rhodiola root and rhizomes was studied by East-European
research groups mainly [24–30]. A decade of investigation
[31, 32] revealed evidences about the presence of diﬀerent
biological active substances in the rhizome of golden root
unlike some other Rhodiola species.
Six diﬀerent groups of chemical components with phar-
maceuticalinterestcouldbefoundintherootsandrhizomes:
(1) phenylpropanoids—alcohol derivatives of the cinna-
mon acid and glycosides like rosavin (2.1%) [33], rosin
and rosarin (which are classiﬁed under the general name
of “rosavins”) [30, 32, 34–36]; (2) phenylethanoids—
salidroside (rhodioloside) (0.8%), p-tyrosol [37–42]; (3) ﬂa-
vonoids—including rodiolin, rodionin, rodiosin, acetylro-
dalgin, tricin [32, 34, 43], and tannins 16–18% [44]; (4)
monoterpenes, including rosiridol and rosidarin; (5) triter-
penes, such as daucosterol and betasitosterol; (6) phenolic
acids such as chlorogenic, hydroxycinnamic, gallic acids [29]
and essential oils [35, 45, 46]. All these substances deter-
mine the speciﬁcity of the Rhodiola extracts. However, the
roots have many other substances like phenolic antioxidant,
including proanthocyanidins, quercetin, gallic acid, and
chlorogenic acid [23, 47].
Rosavins (rosavin, rosarin, and rosin) and the salidroside
or rhodioloside, as well as rodiolin, rodonizid, and roziridine
are the most important, and are mainly used as active sub-
stances for production of medical preparations. Tyrosol is
also a crucial active ingredient; though to a less extent than
the other two standards. The rosavins complex is speciﬁc
for Rhodiola rosea unlike salidroside which presents in other
Rhodiola species and in some plants from other genera [29,
48].
One of the major results of the research is the detection
of diﬀerences in the content of biologically active substances
in the roots of Rh. rosea depending on their habitats [40, 42,
48, 49]. Investigation of rose root from diﬀerent Bulgarian
mountains areas indicated the highest amount of salidroside
of 1.55% in Rila mountain sites, and, respectively, the lowest
of 0.72% in Pirin Mountain sites [50]. The stem and the
leaves contain less salidroside, while there is no substantial
diﬀerence in the levels of polyphenols accumulation in the
epigeous parts of the plant.
2.1. Taxonomy and Morphology. Rhodiola rosea L. (Sedum
roseum (L.) Scop., S. rhodiola DC.), rose root, golden root
(Crassulaceae family) is a species, valuable for the world gene
fund of herbs (medicinal plants) distinguished among the
other 200 species of Rhodiola genus and esteemed for its
outstanding pharmacological importance and use.
Rhodiola rosea L. is a succulent herbaceous, perennial,
and dioecious plant (having separate male or female plants)
with a thick quite branched scaly rhizome (rootstock) with
average weight of 70–400g, but reaching 3.5kg, too. Root
a n dr h i z o m e sh a v er o s es c e n t .S e v e r a ls h o o t sg r o wf r o mt h e
same thick root. The stem is straight, 10–30cm in height
[51]. The leaves are oblong, elliptic-oblanceolate, or obovate,
entire. Inﬂorescences are corymbiform or capitates, the ﬂow-
ers unisexual, ﬂowers are set from April to August. Propaga-
tion is vegetative or by seeds [52].
Golden root grows mainly in the cooler regions of the
world—the Arctic, Scandinavia, North Russia, in the moun-
tains of Asia (the Himalayas, the Altai, and the Ural moun-
tains) and Europe (the Alps, the Pyrenees, the Carpathian
Mountains), and in other higher mountainous regions (980
to 2000m altitude) like those in Bulgaria (the mountains of
Sredna Gora, Rila, Pirin, and the Balkan) [53]. This plant
prefers the scree, grassy, or rocky slopes, from mountain to
subalpine zone of heights up to 2280 meters altitude [54].
Intensive and unscrupulous exploitation of the natural
habitats in many countries has resulted in extinction of the
species in these regions [55]. This provoked undertaking of
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under appropriate conditions, (2) protection of the popula-
tions in the protected territories, (3) including the species in
the Red Books of rare and endangered plant species.
Rhodiola roseaisincludedintheRedBooksofRepublicof
Buryatia AR, of Yakut ASSR, of Mongolia; “Rare and Extinct
Plant Species in Tuva A Republic,” “Rare and Extinct Plant
Species in Siberia,” in Great Britain—Cheﬃngs & Farrell,
in Finland—category “last concerned.” Rhodiola rosea in
Bulgariaisunderprotectionofthelawforbiologicaldiversity
[56].Activitiesconcerningtheprotectionandthesustainable
use of the plant are described by the Law for medicinal
plants [57]. Some Rhodiola rosea populations are included in
reservation areas in the states of the Commonwealth of Inde-
pendent States (CIS) mainly. Rhodiola rosea is successfully
cultivated in botanical gardens and centers for introduction
in Russia (Saint Petersburg, Gorno-Altaysk, Novosibirsk,
Irkutsk, etc.) [58], Finland, and Norway mainly [59].
In Bulgaria, like in the other countries, the number of
natural resources of Rhodiola rosea is decreasing progres-
sively. The restoration capacity of the wild-growing plants
are quite limited due to the very low, both, seed germination
(5–35%) and coeﬃcient of vegetative reproduction [26, 60].
Plants need from 4 to 6 years for optimal development and
maximum accumulation of biologically active substances in
the rhizomes [21, 60].
These data determine the interest towards Rhodiola rosea
for establishment of in vitro cultures as initial raw material
for the pharmaceutical industry and for the plant conserva-
tion.
3.In Vitro Cultures of Rhodiola rosea L.
Despite the great interest to Rh. rosea and the wide investi-
gations in the area of phytochemistry, one potential area—
that of the plant biotechnologies, remains less endeavored
and exploited in comparison to other medicinal species. At
presenttherearemanyscientiﬁcgroupsintheworldworking
on various medicinal plants like Panax ginseng, Arnica mon-
tana, Rauwolﬁa,a n dGalanthus [15–17]. In vitro propaga-
tion has gained distinguished success, and during the last
years it reached large commercial scale, corresponding to
the demands of the pharmacological industry [15]. In spite
of that, there is not an universal protocol applicable to all
species of interest. Usually schemes are established for a par-
ticular plant for speciﬁc purposes. However, accumulation
of experience and knowledge in addition to the empirical
approach is a good basis for elaborating desired schemes for
the target plants.
Pioneerexperimentsongoldenrootinvitrocultureswere
initiated in the nineties of the last century [61–63]. Next fur-
ther research was directed to examine the factors important
for a successful establishment of callus and organogenic cul-
tures which depends mostly on the interactions of the ex-
plant, the nutritious media, the phytoregulators, and the
culture conditions on the plant genetic background. How-
ever, the optimal combinations of these factors could be
determined experimentally for each speciﬁc case.
T h ec h o i c eo ft h ee x p l a n tt y p ei sac r u c i a lf a c t o rf o rs u c -
cessful realization of the morphogenic potential of the isola-
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Figure 1: The relative shares of the most commonly used explants
forinitiationofRhodiolainvitrocultures.Explantwereexcisedfrom
plants growing in their natural environment: (1) leaves, (2) stem,
(3) shoot tips and buds, (4) nodes and rhizome buds, (5) axillary
buds, (6) hypocotyl, and (7) apical buds and stem nodes from in
vitro seedlings.
Figure 2: Rh. rosea plant regeneration from in vitro seedling
apical buds on Murashige and Skoog (MS) [64] basal medium
enriched with 2mg/L zeatin, 0.2mg/L IAA, and 1000mg/L casein
hydrolysate.
ted cells. The explant could determine the organogenic and
the genetic stability of the progeny after cloning. This is the
reason for the great number of explants used for initiation of
in vitro cultures in Rh. rosea.
Leaves or leaf disks were preferable explants for callus,
bud, and shoot formation [62, 65–68]. Explants of less use
were axillary buds [63], stem segments [67, 69], shoot tips
and buds [69–71], and node and rhizome buds [69, 72]
excised from plants growing in their natural environment
and in vitro (Figure 1). Apical buds and stem nodes from in
vitro seedlings were the object of others’ investigations [69,
73, 74] (Figures 2 and 3). Obtained data reveal that experi-
ments in the diﬀerent laboratories have contradictory suc-
cess.
The nutritious media and the phytoregulators are the
other very important factors inﬂuencing the processes of cal-
logenesis, organogenesis, regeneration, and multiplication in
vitro.Thechemicalcompositionofthemediaanditsphysical4 The Scientiﬁc World Journal
(a) (b)
Figure 3: Rh. rosea plant regeneration from in vitro seedling leaf nodes (a); shoot multiplication (b) and ﬂowering regenerant on MS basal
medium enriched with 2mg/L zeatin, 0.2mg/L IAA, and 1000mg/L casein hydrolysate.
properties should correspond to the requirements of each
stage of culture development [17, 75]. The test of diﬀerent
recipes of Murashige & Skoog (MS), Linsmaer & Skoog,
Gamborg, White, and Nitsch & Nitsch showed that the last
one was the best for plant development from shoot tips,
while MS medium allowed various responses from diﬀerent
explants [65]. MS medium, compared to these of Litvay and
of White, proved to be better for evaluation of morphogenic
potential of Rh. rosea and Rh. iremelica [70]a sw e l la sf o r
c a l l u sc u l t u r e sa n dr e g e n e r a t i o ni nT i b e t a nRh. rosea [76].
TheMurashigeandSkoogmediumbecamethemostpopular
one for golden root in vitro cultures. Usually it is supplemen-
ted with various growth regulators in diﬀerent combinations
and concentrations. The most commonly used are 6-benzyl-
aminopurine (BAP), indole-3-acetic acid (IAA), l-naphthyl
acetic acid (NAA), indole-3-butyric acid (IBA), and 2,4-
dichlorophenoxy acetic acid (2,4-D) [62, 65–67, 69, 70]b u t
the eﬀect of zeatin, dimethylaminopurine (2-iP), kinetine,
and thidiazuron (TDZ) was examined, too [69, 71–73]( F i g -
ures 4, 5,a n d6).
However, the eﬃciency of the plant growth regulators is
in relation to the genetic background which was proven in
the experiments with various Rhodiola rosea ecotypes [70].
The best results for revealing the morphogenetic potential
could be achieved by the appropriate balance between the
explant and the media enriched with phytoregulators and
other nutritious supplements and the genotype. These are
thethreemilestonesintheexperimentsofeachgroupaiming
at establishment of Rhodiola in vitro cultures. Achievements
in induction of organogenic and callus cultures, regenera-
tion, and micropropagation varied, and some examples are
presented in this review.
Leaf segments were used in one of the ﬁrst investiga-
tions for induction of shoots and callus formation [62]. The
response of this explant type was evaluated on quite a great
number (15 variants) of Murashige and Skoog medium
[64]. The importance of BA, both for dediﬀerentiation and
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Figure 4: The relative shares of the most commonly used plant
phytoregulators for Rhodiola callus induction in vitro.
rediﬀerentiation processes was pointed out. This cytokinin
in the absence of auxins caused adverse eﬀect on leaf viability
and callus formation. However, the ratio between its concen-
trations and that of IAA and NAA, determined induction of
callogenesis and organogenesis. Callus and root formations
wasstimulatedbyisomolarlevelsof5μM/LeachBAandIAA
while shoot formation was more eﬃcient when the BA con-
centration was higher than the concentration of the auxin
NAA 0.5μM/L.
Nearlyatthesametimequitedetailedinvestigationswere
performed to study the interaction between two explant
types and diﬀerent nutritious media and growth regulators
on the regeneration and callogenesis potential of Rh. rosea
[65]. Using leaf segments and shoot tips diﬀerent combina-
tions of BA, Kin, IAA, 2,4-D, NAA and 2-iP were tested. The
most favorable conditions for shoot formation were shoot
tipscultivationfor8weeksonNitsch&Nitsch(NN)medium
supplemented with 0.1mg/L IAA and 0.1mg/L or 1mg/L
kinetin. The same media favored root formation, too.The Scientiﬁc World Journal 5
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Figure 5: The relative shares of the most commonly used plant
phytoregulators for Rhodiola bud and shoot induction in vitro.
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Figure 6: The relative shares of the most commonly used plant
phytoregulators for Rhodiola root induction in vitro.
However,additionofBAandIBAtoNNmediumledtolower
levels of regeneration and to inhibition of the growth when
NAA was included. Complete suppression of development of
explants from leaf, hypocotyls, and shoot tips was observed
on Linsmaer & Skoog medium containing 2-iP and IAA.
Callogenesis was induced only by leaf segments plated on
Gamborg-B5, Gibco, and MS media. However, adequate
growth was observed on the last medium containing BA and
NAA, or BA and IBA.
Ad i ﬀerent approach was used in other experiments [66].
Suitable plant material for initiation of shoot cultures was
seedswhichbeforeinvitrogerminationweretreatedwithlow
temperature of 2–4◦C for a period of 4 and 6 months or with
0.02% GA3 for 24 hours. These procedures replaced success-
fully the seed stratiﬁcation. Stem segments, stem apex, and
leaf explants excised from the seedlings were cultured on
MS medium enriched with BA and IAA in diﬀerent ratio of
concentrations from 1mg/L to 3mg/L of the cytokinin and
from 0.8mg/L to 2.6mg/L of the auxin. The most eﬃcient
direct organogenesis was from leaf explants on MS medium
supplemented with 2mg/L BAP and 1.7mg/L IAA.
Seeds and rhizomes from three ecotypes from the High
Altai and South Ural region served as the explant source
to study induction of callogenesis and organogenesis [70].
Explant development was observed on MS media containing
various phytoregulators (BAP, IAA, NAA, IBA, 2,4-D). Vigo-
rouscallusformationof86%oftheexplantswasobservedon
MS medium enriched with 0.1-0.2mg/L IAA. The optimal
combination for multiple bud formation in Rhodiola rosea
from stem segments was BAP and IAA in concentrations
of 0.2mg/L and 0.1mg/L, respectively, while for Rhodiola
iremelica the eﬃcient concentrations were lower—0.1mg/L
BAP and 0.05mg/L IAA. Diﬀerences in ecotype appeared to
be also an important factor inﬂuencing the processes of eﬃ-
cient callogenesis and organogenesis. Regenerants were ini-
tially adapted in vermiculite for two weeks in conditions of
high humidity (85–90%) and later plants were transferred to
mixtureofsoil,peat,andvermiculiteinproportionof1:1:1.
Plantlets revealed considerable diﬀerences (from 10% to
95%) in the survival rate during the process of adaptation. In
the later experiments [76] the eﬀect of Rh. rosea extracts on
the morphogenic abilities of Rh. rosea and Rh. iremelica were
studied. Addition of 5% or 10% v/v liquid extracts in the MS
medium provoked diﬀerent in vitro responses. Bud induc-
tion was stimulated by the lower concentration and inhibited
by the higher ones leading to formation of 8.5 shoots from
the explants in the ﬁrst case and 1.1 in the second case.
In comparison to the previously described investigations
with the Altai ecotype of Rhodiola rosea the optimal concen-
trations of the cytokinin BAP were 10–15-fold higher for
induction of in vitro cultures from immature leaves explants
from a Tibetan ecotype of golden root [67]. The authors
note interaction between the growth regulators and the illu-
mination of the cultures. Two mg/L BA and 0.2mg/L NAA
addedtotheMSmediumstimulatedformationofincompact
callus tissue. However, when explants were cultivated under
darkconditions,higherconcentrationsofthesamephytoreg-
ulators 3mg/L BA and 0.25mg/L NAA were more eﬃcient.
MS medium containing 2mg/L BA and 0.25mg/L NAA in-
ducedshootmultiplicationwhilerootingwasinducedonMS
medium containing 0.5mg/L or 1mg/L IAA.
Recently [71] in vitro micropropagation of rose roots in a
RITA bioreactor system was reported for the ﬁrst time. Three
clones were obtained from in vitro germinated seedlings
of wild Finland golden root. The eﬀect of two stimulators
of organogenesis was studied. Two to four μM thidiazuron
stimulated shoot induction but inhibited shoot growth while
1-2μM zeatin favored increasing shoot size and leaf number
per shoot. The clones diﬀered signiﬁcantly in respect to mul-
tiplication rate. One of them was distinguished for its high
coeﬃcient of shoot formation per explant on solidiﬁed med-
iumenrichedwith2μMzeatin.Inthebioreactorthidiazuron
maintained rapid shoot proliferation at quite concentration
(0.5μM) but induced hyperhydracity at more than 0.5μM.
However, hyperhydracity was abolished when shoots were
transferred for 4 weeks on gelled medium enriched with
1-2μM zeatin. Shoots formed roots for 5-6 weeks on BM
medium without phytoregulators. Most of the regenerants
(85–90%) survived when transferred to soil. After acclima-
tization, the plants growing in the green house had normal
s h o o ta n dl e a fm o r p h o l o g y .6 The Scientiﬁc World Journal
Figure 7: Induced rhizogenesis and propagation in Rh. rosea regenerated plants on MS medium enriched with 2.0mg/L IBA, 0.2mg/L IAA,
and 0.4mg/L GA3 [69].
An extensive research with Bulgarian Rh. rosea ecotype
brought the development of a complete system for obtaining
callus cultures, shoot induction and multiplication, micro-
propagation, and reintroduction of regenerants to the natu-
ral environment of the rose root. Success was based on the
investigations of the interaction between numerous explant
types, media supplements, and culture conditions. In the
initial experiments [73, 74] apical buds and stem nodes
excised from in vitro germinated seedlings/plants were used.
Another series of experiments [69] examined the morpho-
genic potential of ﬁve types of explants obtained from wild-
growing plants (apical buds, adventitious shoots, stem ex-
plants, rhizome buds, and rhizome segments). Diﬀerent in
vitro responses were observed—formation of plantlets, leaf
rosette, various types of callus (compact green, pale, soft
liquidy) and callus degeneration without bud formation. In
another series of experiments the authors cultivated explants
excised from 15–25mm high seedlings—apical bud, stem
segment with leaf node, and explants excised from the seedl-
ing root basal area. The stem segment with leaf nodes and
apical buds were the best explants for in vitro propagation.
Morphogenic potential was studied on MS basal medium
containing a range of phytoregulator combinations, includ-
ing basically benzyl adenine, kinetin, zeatin, 2-iP, 2,4-D,
NAA, and IAA. Excised leaf nodes and apical buds from
seedlingsculturedinvitroprovedtobeagoodsolutioninthe
investigations for overcoming the problems when working
with wild plants. The both explants regenerated shoots with
highest eﬃciency of more than 80% on zeatin containing
media.Thezeatinandthe2-iP,comparedtokinetinandBAP,
stimulated growth and formation of shoots from seedling
leaf nodes and apical buds. The signiﬁcance of zeatin for
numerous bud/shoot formations was pointed out. It was
interesting to note that the coeﬃcient of propagation varied
during the diﬀerent seasons. Highest level of proliferation
was observed in May-June, when the shoots per explant were
6.78. During the cold seasons multiplication was relatively
lower—2.11 shoots per explant [77].
Rhizogenesis was stimulated by IBA in increasing con-
c e n t r a t i o n su pt o2m g / La n dw a sm o s te ﬃcient when IBA
and IAA were applied in combination (Figure 7). The regen-
erants 3–5cm in height which had 2-3cm long roots were
transferred to pots containing a mixture of soil:peat:perlite
in a ratio 3:1:1 and were maintained for 20 days for adap-
tation in special chambers (Figure 8). Acclimatization of
rootedgoldenrootplantletsintothegreenhousewassuccess-
ful up to 70% [69, 77].
In vitro obtained plants were phytochemical analyzed for
the presence of biologically active substances which were
not found in the roots of one-month-old regenerants in
test tubes (unpublished data). However, salidroside was pro-
duced in the rhizome and roots of one- and two-year old
regenerants grown in the mountains [78] and in the green
house (Figure 9) (unpublished data). The results were pro-
mising as far as salidroside content of regenerants was higher
than that of the wild plants.
In vitro plants obtained on diﬀerent culture media were
subjected to cytological analysis. However, procedures for
squashpreparations weremodiﬁed tobe applicabletomeris-
tematic cells of root tips of Rhodiola rosea regenerants. The
chromosomenumberinallsampleswas2n = 22,whichcon-
ﬁrmed the diploid level of plant regenerants and cytogenetic
identity with the wild-type (Figure 10)[ 79]. Concerning
ﬂowers,leaves,stem,andrhizomesnodiﬀerenceswererecor-
ded between the wild plants and the regenerated plants
g r o w nf o r1a n d2y e a r sex vitro in the adaptation room, in
the green house, and in the mountain.
Asaresultoftheexperimentseﬃcientschemesforregen-
eration and micropropagation of Rh. rosea were established,
despite the diﬃculties working with wild species. The diﬀer-
ent schemes for eﬃcient micropropagation, utilizing a range
of media and several types of explants, allow ﬂexibility in the
investigations. These schemes varied in time duration, labor
consumption, and costs.The Scientiﬁc World Journal 7
Figure 8: Adaptation of Rh. rosea regenerants in mixture of perlite,
peat, and soil [69].
Figure 9: Roots and rhizomes of in vitro regenerated plant culti-
vated two years in the green house [79].
A recommendable protocol could be the following one:
(1) seeddecontaminationbyEtOHfor3minfollowedby
20% v/v bleach for 15min and germination on MS
media containing 5–100mg/L gibberellic acid;
(2) shoot multiplication from leaf nodes from seedlings
or regenerants on MS enriched either with 2mg/L
zeatin, 0.2mg/L IAA, and 1000mg/L casein hydro-
lysate or with 0.2mg/L zeatin and 0.2mg/L IAA (or
for a longer period on MS with 1mg/L BA and
0.1mg/L IAA or 0.5mg/L BA and 0.1mg/L); rooting
of plantlets on MS with addition of either 0.2mg/L
IAA, 2.0mg/L IBA, 0.4mg/L GA3 or 0.2mg/L IAA,
2.0mg/L IBA, 0.1mg/L GA3;
(3) in vivo adaptation in a combination of perlite, peat,
and soil in ratio of 1:1:3.
The whole process could take about three months. For
this period more than 100 regenerated plantlets could be
Figure 10: “Squash” preparation of meristematic cells of root tips
excised from in vitro plant regenerants of Rhodiola rosea having
diploid chromosome number of 2n = 22 [79].
propagated from one seedling of rose root. Each regenerant
could give three to ﬁve explants for further clonal propaga-
tion.
Remarkable success of this work was the adaptation of in
vitro obtained regenerants to the wild high mountain con-
ditions which was not reported by others. This success allows
restoration of the habitats and conservation of germplasm
of the endangered medicinal species rose root. Accumulation
of biomass by micropropagation and salidroside synthesis
by in vitro regenerants conﬁrm the potential of this ecology
friendly biotechnological method forthe productionof valu-
ablesubstancesfromRhodiola rosea.Thepresentconclusions
were proved by authors’ further phytochemical analysis of
salidroside, rosavin, rosin, and rosarin by HPLC detection in
roots and rhizomes of in vitro plants, reintroduced in nature
(unpublished data).
4. Potentialof Biotechnological Methods for
IncreasingBiologically Active Substances
Production by Rhodiola rosea
The plants are traditional source of quite a big number of
biologically active substances used in the pharmaceutical
industry. The most valuable phytochemicals are products of
the secondary metabolism. Most of them have complicated
structure which makes their chemical synthesis very diﬃcult
and even impossible. Plant in vitro c u l t u r e sa r ea b l et op r o -
duce and accumulate a lot of substances esteemed by the
pharmacy and the medicine.
After establishment of in vitro cultures, research con-
tinues for their implementation in practice. Plant in vitro
cultures oﬀer possibilities for production of valuable sec-
ondary metabolites in bioreactors, for manipulation of the
metabolic pathways and metabolic engineering, and for bio-
transformation. The latter is one of the key mechanisms for
improvement of biologically active substances production in
Rhodiola rosea callus and cell suspension cultures. However,8 The Scientiﬁc World Journal
there are not so many reports on Rhodiola in vitro cultures
used for a production of biologically active substances and
for a determination of the optimal parameters for their syn-
thesis in vitro.
The possibilities of cell suspension cultures initiated
from leaf explant callus were studied [80] for increasing
the synthesis of rosavin and other cinnamyl glycosides
after addition of transcinnamyl alcohol (optimal concen-
tration of 2.5mM) into the liquid MS medium. For about
3 days more than 90% of the alcohol was transfor-
med by the cells into various unidentiﬁed products. How-
ever,oneofthem,3-phenyl-2-propenyl-O-(6 -O-α -L-arabi-
noryranosyl)-β-D-glucopyranoside, found in the intracellu-
lar spaces, was deﬁned as potential rozavin by very precise
methods. Both green and yellow strains of cell cultures were
able to glycosylate trans-cinnamyl alcohol into rosavin with
y i e l do f0 . 0 3t o1 . 0 1 %c e l ld r yw e i g h t .
The eﬀect of diﬀerent precursors of biologically active
substances on the biomass and the metabolite production
was studied in Rhodiola compact callus aggregates in liquid
medium [81, 82]. Cinnamyl alcohol concentrations up to
0.1mM in media did not bring to a signiﬁcant deviation
from the control; 2 to 5mM changed slightly callus color
from dark to light green. In these cultures rosin content was
elevated to 1.25% dry weight while rosavin was 0.083% dry
weight.Cinnamyl alcoholinducedsynthesis of fournewpro-
ducts, too. Tyrosol from 0.05mM and 2mM did not inﬂu-
ence callus growth while concentrations of 3mM up to
9m Mc a u s e dd e c r e a s ei nb i o m a s sp r o d u c t i o n .T w om Mo f
tyrosol were the optimal levels for salidroside production
reaching 2.72% dry weight. Addition of glucose had no posi-
tive eﬀect on salidroside accumulation but doubled the rosin
production.
Callus tissues cultivated on solid media could produce
active substances characteristic for the species [83]. Addition
of yeast extract in the media doubled salidroside content
(from 0.8% to 1.4) and was twice as high as in ﬁve-year-
old roots of the intact plants. In the later experiments [84]
callus induced from axillary buds or from seedling hypo-
cotyls transformed exogenous cinnamyl alcohol into rosin.
However, the biotransformation process was more eﬃcient
in the hypocotyl callus where the application of 2.5mM cin-
namyl alcohol resulted in the increase of rosin content up to
1056.183mg/100g on solid medium and 776.330mg/100g
in liquid medium. Callus tissue obtained from axillary buds
and treated in the same way produced rosavin in a higher
concentration of 92.801mg/100g and reached 20% of the
amount produced by roots [85]. The extract enriched in
rosavins (after transformation) showed the inhibition of
behavioral activity of the tested animals—rats.
Induction of callogenesis was successful [86]f r o ml e a f
explants, isolated from in vitro propagated plants, on MS
media enriched with BAP in concentration from 0.5mg/L
to 2.0mg/L; 2-iP—0.3 and 3.0mg/L; 2,4-D—from 0.1
to 2.0mg/L; IAA—0.2, 0.3 and 1.0mg/L; NAA—0.5, 1.0,
1.5mg/L; glutamine—150mg/L and casein hydrolysate
1000mg/L. The highest response to formation of callus
(62.85% and 73.17%) was observed on two media-con-
taining 1mg/L BAP and either 1mg/L or 0.5mg/L 2,4-D
(Figure 11).
Callogenesis was not observed in any of the variants con-
taining 2-ip and most of the variants containing NAA. In this
pioneer study optimal combinations and concentrations of
phytoregulators were determined for eﬃcient induction and
maintaining of callus amenable for long-term cultivation (6
months) (Figure 12).
Total phenolic/ﬂavonoid content and radical scavenging
activity was determined in calli. Antioxidant properties were
inﬂuencedbythecompositionofthecultivationmedia.Rela-
tionship between the callus color/structure/texture and the
secondary metabolite amounts was not signiﬁcant. Linear
correlation between the total phenolic/ﬂavonoid content and
the scavenging activity was observed. Bioinformatics prog-
nosisfortheoptimalrecipesofthenutritionmediawasmade
based on the analysis of the data obtained in the biological
experiments (unpublished data). This study is a pioneering
one concerning establishment and maintaining of Bulgarian
golden root callus cultures and determination of their phy-
tochemical properties and could be a basis for in vitro meta-
bolic engineering and biotransformation for alternative pro-
duction of valuable substances.
5.In Vitro Cultures of Rhodiola Genus
Genus Rhodiola consists of 200 polymorphic species. How-
ever, less than 20 Rhodiola species including Rh. alterna,
Rh. brevipetiolata, Rh. crenulata, Rh. kirilowii, Rh. quadri-
ﬁda, Rh. sachalinensis,a n dRh. sacra have pharmacological
importance for production of medications [20]. All species
of the genus contain diﬀerent quality of salidroside—one of
thebasiccomponentsofthebiologicallyactivecomplex.Bio-
technological research focuses mainly on the species distin-
guished for their high levels and quality of the substances,
valuable for the pharmacological industry. Targets of the
experimentsareinductionofcallusandorganogeniccultures
followed by plant regeneration aiming at alternative in vitro
synthesis of the desired metabolites and at development of
eﬃcient systems for micropropagation for conservation of
the species.
The possibility for induction and maintaining of callus
cultures was studied [87]i nRhodiola quadriﬁda, a species
used in traditional Chinese medicine for more than 1000
years.CallusinductionwasinducedonMSmediumenriched
with 2,4-D (1.0mg/L), NAA (2.0mg/L), BA (0.5mg/L), and
kinetin (0.1mg/L) and maintained on the same basal med-
ium supplemented with 2,4-D (1.0mg/L), 6-BA (0.1mg/L),
and kinetin (0.5mg/L). Analysis of one-month-old callus
showed that the nondiﬀerentiated tissues were able to pro-
duce salidroside. The authors underlined the role of 2,4-D
andBAforproductionofbiologicallyactivesubstances.Sim-
ilar observations about the role of the explant, the tem-
perature of cultivation and the pretreatment duration were
made in another work [88] on salidroside synthesis in callus
obtained from leaf and stem segments of Rhodiola kirilowii.
Experimentsoncallusinductionfollowedbyplantregen-
eration of Rhodiola coccinea [89] revealed the importance
of callus characteristics for their morphogenic abilities.The Scientiﬁc World Journal 9
(a)
(b)
Figure 11: Callus cultures cultivated for 40 days on diﬀerent media: variant (a) MS medium enriched with 1mg/L BAP, 0.5mg/L NAA and
1000mg/L casein hydrolysate; variant (b) MS medium containing 0.5mg/L BAP and 1mg/L IAA.
(a) (b)
Figure 12: Callus growth after the 3rd passage on diﬀerent media: variant (a) MS medium enriched with 0.5mg/L BAP and 1mg/L 2,4-D;
variant (b) MS medium enriched with 1mg/L BAP and 0.5mg/L 2,4-D.
Onlyoneoutofthethreecallustypeswereembryogenic.The
latter was induced on MS medium containing BA (0.5mg/L)
andIAA(2.0mg/L).Diﬀerentiationandshootformationwas
possible by including BA (0.05mg/L) and IAA (0.5mg/L) in
the medium. Five callus types using diﬀerent explants from
root, stem, leaves, and cotyledons of Rhodiola sachalinesis A.
Bor. were obtained, too [90]. MS medium containing the
phytoregulators BA 3mg/L, NAA 0.3mg/L, and temperature
of 21–25◦C were suitable for callus induction. The same spe-
cies was an object of other authors [91] who succeeded to10 The Scientiﬁc World Journal
induce callus formation (with yellow, green, and red colors)
in 88.33% of the leaf explants. BA (2.0mg/L) and NAA
(0.5mg/L) were also the eﬀective phytoregulators included
in MS medium. The authors found out that only green callus
w a sa b l et of o r mb u d so nM Sm e d i u mw i t hl o w e rc o n c e n -
trations of the same phytoregulatorsBA (1.0mg/L) and NAA
(0.1mg/L). However, induction of organogenesis was at
comparatively low level (21.33%) and needed longer period
of time of 50 days. Despite this regenerated plantlets were
rooted on half strength MS medium. Cryopreservation of
calli induced from seedling explants of the same species Rho-
diola sachalinesis was successful achieved [92]. The recovery
of fresh and green tissues was possible for 6 weeks on nutri-
ent medium containing BA 2.0mg/L and NAA 0.5mg/L.
Rhodiola sachalinesis was an object in the sophisticated
experiments of obtained protoplast cultures [93]. Mesophyll
protoplasts were isolated from leaves of in vitro regenerated
plants. The protoplasts which regenerated cell wall, divided
toformcoloniesandcalliforaperiodof40daysonMSmed-
ium enriched with 2,4-D—1.0mg/L, zeatin—0.5mg/L,
0.5M/L mannitol, and casein hydrolysate 500mg/L were
transferred to poorer medium containing only BA and NAA
(1.0mg/L and 0.1mg/L, resp.). Organogenesis was induced
and buds appeared after the p-calli. The shoots developed
f o r m e dr o o t so nh a l fs t r e n g t hM Sm e d i u m .
System for in vitro cultivation of Rhodiola sachalinensis
callus aggregates for production of salidroside was estab-
lished [94]. Its biosynthesis was in standard levels, making
the system promising for alternative production of the
valuable metabolite.
The possibility for in vitro propagation of four Rhodiola
species—Rh. crenulata, Rh. yunnanensis, Rh. fastigata,a n d
Rh. sachalinesis using two types of explants was studies [68].
Stem explants were more suitable for bud induction from
Rh. crenulata, while leaf material was more eﬃcient for orga-
nogenesis in the other three species. The genotype and the
phytohormoneswereimportantfortheeﬃciencyoftherege-
neration. The optimal combination of phytoregulators for
organogenesis in Rh. crenulata and Rh. yunnanensis was
2.5mg/L BA and 0.1mg/L NAA which stimulated bud for-
mation in 71% and 84% in Rh. crenulata and Rh. yun-
nanensis, respectively. The medium containing the higher
concentrations of NAA (0.5mg/L) and BA (2.5mg/L) was
more appropriate for Rh. fastigata and Rh. sachalinesis bud
formation 80% of the cases. The shoots from the last two
species formed roots easily (87% and 73%, resp.) on med-
ium containing IBA. Regenerants from Rh. fastigata were
successfully adapted for further in vivo development in soil
reaching survival rate of 66%.
In vitro cultures of Rhodiola crenulata aiming at estab-
lishment of technology for in vitro multiplication of the spe-
cies were developed [95].Diﬀerent explants from wild-grow-
ing plants were cultivated on MS basal media with various
combinations of plant growth regulators: leaf discs on BA
2.0mg/L and IAA 0.2mg/L; ﬂower buds on 2.0mg/L kinetin;
stem nodes on 2.0mg/L BA and 1.0mg/L IAA; stem explants
on 2.0mg/L kinetin and 1.0mg/L IAA. Leaf explants proved
to be the most suitable for in vitro development with 100%
shoot induction on MS medium containing 0.2mg/L NAA.
The other explant types did not show any development for
the adequate period of time. The authors put the basis for
micropropagation of Rh. crenulata.
Accumulation of biomass through micropropagation
and the production of biologically active substances in in
vitro cultures conﬁrm the potential of this environmentally
friendly technology to be used for production of Rhodiola
valuable substances.
6. Conclusion
Plant biotechnologies of Rhodiola rosea and other Rhodiola
species have marked considerable success for their short
historical period of 20 years. The ﬁrst investigations on the
factors important for the initiation of in vitro cultures were
deepened and broadened and led to the establishment of
complete schemes for micropropagation and systems for
production of biologically active substances. During the last
years more groups have been involved in the research. The
number of examined ecotypes and genotypes of golden
root has been increasing and has been covering more
Rhodiola species. More up-to-date approaches and sophis-
ticated instrumentation have been used which would bring
further success to the alternative biosynthesis of valuable
Rhodiola metabolites and to protection of this precious rare
endangered medicinal plant.
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